Schrödinger Inc., an American computational software developer for drug discovery, has raised a US$85 million financing round, led by The Bill and Melinda Gates Foundation Trust and Chinese biopharmaceutical company WuXi AppTec’s Corporate Venture Fund, according to an announcement released last Friday.
